Product 2017-09-13T19:13:24+00:00

BO-112: a Potent Immunotherapy

BO-112, Bioncotech’s lead product, is a synthetic dsRNA complex targeting cytosolic helicases MDA5 and RIG-I as well as toll-like receptor TLR3. BO-112 has demonstrated safety and intended biological effect in clinical trials as a monotherapy, and is currently being investigated in combination with checkpoint inhibitors.

BO-112 bioncotech immunotherapy